关键信息
-
基因名
GH2
- 应用
-
别名
GH-V; GHL; GHV; hGH-V; Growth Hormone Variant; Placenta-Specific Growth Hormone; Placental Specific Growth Hormone
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P01242
-
表达区间
Phe27~Phe217
-
分子量
26kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
The research on GH2 recombinant proteins focuses on the study of growth hormone, specifically the GH2 isoform, which plays a crucial role in growth and metabolic regulation in various species, including humans. Growth hormone is primarily produced by the pituitary gland and is vital for normal physical development and metabolic processes. The GH2 protein exhibits significant structural and functional differences compared to other isoforms, leading to an increased interest in understanding its unique biological roles and therapeutic potential. The recombinant production of GH2 proteins allows for detailed structural studies, functional assays, and the exploration of their applications in biomedical research and clinical therapies. Advances in recombinant DNA technology have enabled scientists to produce these proteins in various host systems, facilitating large-scale production and purification, essential for extensive studies on its effects on growth, metabolism, and various disorders associated with GH deficiencies or abnormalities. Overall, the investigation into GH2 recombinant proteins presents valuable insights into growth modulation, potential treatment options for growth disorders, and applications within regenerative medicine and biopharmaceuticals. This research sheds light on the complex mechanisms of hormone action, allowing for the development of targeted therapies that could improve health outcomes related to growth and development.
